207 related articles for article (PubMed ID: 35901768)
1. Cost-effectiveness analysis of endovascular treatment with or without intravenous thrombolysis in acute ischemic stroke.
Qureshi AI; Akinci Y; Huang W; Ishfaq MF; Hassan AE; Siddiq F; Gomez CR
J Neurosurg; 2023 Jan; 138(1):223-232. PubMed ID: 35901768
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of endovascular thrombectomy with alteplase versus endovascular thrombectomy alone for acute ischemic stroke secondary to large vessel occlusion.
Ye Z; Zhou T; Zhang M; Zhou J; Xie F; Hill MD; Smith EE; Busse JW; Zhang Y; Liu Y; Wang X; Ma Z; An Z
CMAJ Open; 2023; 11(3):E443-E450. PubMed ID: 37192770
[TBL] [Abstract][Full Text] [Related]
3. Endovascular Thrombectomy with or without Bridging Thrombolysis in Acute Ischemic Stroke: A Cost-Effectiveness Analysis.
Morsi RZ; Zhang Y; Zhu M; Xie S; Carrión-Penagos J; Desai H; Tannous E; Kothari SA; Khamis A; Darzi AJ; Tarabichi A; Bastin R; Hneiny L; Thind S; Siegler JE; Coleman ER; Mendelson SJ; Mansour A; Prabhakaran S; Kass-Hout T
Neuroepidemiology; 2024; 58(1):47-56. PubMed ID: 38128500
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of thrombectomy alone versus alteplase before thrombectomy in acute ischemic stroke: results from the DIRECT-MT.
Ma H; Zhou Y; Gao L; Liu P; Zhang L; Xing P; Li Z; Shen H; Zhang H; Zhang Y; Zhang X; Hua W; Zhang Y; Liu J; Yin C; Yang P
J Neurosurg; 2023 Sep; 139(3):678-686. PubMed ID: 36790013
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of mechanical thrombectomy plus tissue-type plasminogen activator compared with tissue-type plasminogen activator alone for acute ischemic stroke in France.
Kaboré N; Marnat G; Rouanet F; Barreau X; Verpillot E; Menegon P; Maachi I; Berge J; Sibon I; Bénard A
Rev Neurol (Paris); 2019 Apr; 175(4):252-260. PubMed ID: 30642680
[TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness of Endovascular Stroke Therapy: A Patient Subgroup Analysis From a US Healthcare Perspective.
Kunz WG; Hunink MG; Sommer WH; Beyer SE; Meinel FG; Dorn F; Wirth S; Reiser MF; Ertl-Wagner B; Thierfelder KM
Stroke; 2016 Nov; 47(11):2797-2804. PubMed ID: 27758942
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of endovascular thrombectomy in acute stroke patients with large ischemic core.
Sanmartin MX; Katz JM; Wang J; Malhotra A; Sangha K; Bastani M; Martinez G; Sanelli PC
J Neurointerv Surg; 2023 Nov; 15(e2):e166-e171. PubMed ID: 36175016
[TBL] [Abstract][Full Text] [Related]
8. Lifetime quality of life and cost consequences of delays in endovascular treatment for acute ischaemic stroke: a cost-effectiveness analysis from a Singapore healthcare perspective.
Ni W; Kunz WG; Goyal M; Ng YL; Tan K; De Silva DA
BMJ Open; 2020 Sep; 10(9):e036517. PubMed ID: 32948553
[TBL] [Abstract][Full Text] [Related]
9. Endovascular Thrombectomy Alone versus Combined with Intravenous Thrombolysis.
Phan K; Dmytriw AA; Maingard J; Asadi H; Griessenauer CJ; Ng W; Kewagamang K; Mobbs RJ; Moore JM; Ogilvy CS; Thomas AJ
World Neurosurg; 2017 Dec; 108():850-858.e2. PubMed ID: 28823660
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of remote robotic mechanical thrombectomy in acute ischemic stroke.
Sanmartin MX; Katz JM; Eusemann C; Boltyenkov AT; Sangha K; Bastani M; Turner R; Siddiqui AH; Mendes Pereira V; Hui FK; Mocco J; Sanelli PC
J Neurosurg; 2023 Sep; 139(3):721-731. PubMed ID: 36670531
[TBL] [Abstract][Full Text] [Related]
11. Is concurrent intravenous alteplase in patients undergoing endovascular treatment for large vessel occlusion stroke cost-effective even if the cost of alteplase is only US$1?
Ospel JM; McDonough R; Kunz WG; Goyal M
J Neurointerv Surg; 2022 Jun; 14(6):568-572. PubMed ID: 34187871
[TBL] [Abstract][Full Text] [Related]
12. Endovascular Treatment in Patients with Persistent Internal Carotid Artery Occlusion after Intravenous Tissue Plasminogen Activator: A Clinical Effectiveness Study.
Hong JH; Sohn SI; Kang J; Jang MU; Kim BJ; Han MK; Park TH; Park SS; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Cho KH; Kim JT; Choi JC; Lee J; Lee JS; Gorelick PB; Bae HJ
Cerebrovasc Dis; 2016; 42(5-6):387-394. PubMed ID: 27359223
[TBL] [Abstract][Full Text] [Related]
13. IV tPA is associated with increase in rates of intracerebral hemorrhage and length of stay in patients with acute stroke treated with endovascular treatment within 4.5 hours: should we bypass IV tPA in large vessel occlusion?
Hassan AE; Ringheanu VM; Preston L; Tekle W; Qureshi AI
J Neurointerv Surg; 2021 Feb; 13(2):114-118. PubMed ID: 32620575
[TBL] [Abstract][Full Text] [Related]
14. Endovascular thrombectomy in patients with large core ischemic stroke: a cost-effectiveness analysis from the SELECT study.
Sarraj A; Pizzo E; Lobotesis K; Grotta JC; Hassan AE; Abraham MG; Blackburn S; Day AL; Dannenbaum MJ; Hicks W; Vora NA; Budzik RF; Sharrief AZ; Martin-Schild S; Sitton CW; Pujara DK; Lansberg MG; Gupta R; Albers GW; Kunz WG;
J Neurointerv Surg; 2021 Oct; 13(10):875-882. PubMed ID: 33188155
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of endovascular treatment for acute ischaemic stroke in Thailand.
Rattanavipapong W; Worakijthamrongchai T; Soboon B; Luankongsomchit V; Kongmuangpuk M; Isaranuwatchai W; Teerawattananon Y; Nilanont Y
BMJ Open; 2022 Sep; 12(9):e064403. PubMed ID: 36167373
[TBL] [Abstract][Full Text] [Related]
16. A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke.
Kim AS; Nguyen-Huynh M; Johnston SC
Stroke; 2011 Jul; 42(7):2013-8. PubMed ID: 21636817
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of recombinant tissue-type plasminogen activator for acute ischaemic stroke with unknown time of onset: a Markov modelling analysis from the Chinese and US perspectives.
Zhao S; Cheng Y; Tong X; Han M; Ji L; Che Y; Hu W; Liu A
BMJ Open; 2022 Nov; 12(11):e065133. PubMed ID: 36375982
[TBL] [Abstract][Full Text] [Related]
18. Pre-thrombectomy intravenous thrombolytics are associated with increased hospital bills without improved outcomes compared with mechanical thrombectomy alone.
Hassan AE; Kotta H; Garza L; Preston L; Tekle W; Sarraj A; Qureshi AI
J Neurointerv Surg; 2019 Dec; 11(12):1187-1190. PubMed ID: 31103991
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness of Endovascular Treatment in Large Vessel Occlusion Stroke With Mild Prestroke Disability: Results From the HERMES Collaboration.
Ospel JM; Kunz WG; McDonough RV; van Zwam W; Pinckaers F; Saver JL; Hill MD; Demchuk AM; Jovin TG; Mitchell P; Campbell BCV; White P; Muir K; Achit H; Bracard S; Brown S; Goyal M;
Stroke; 2023 Jan; 54(1):226-233. PubMed ID: 36472199
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
Tan Tanny SP; Busija L; Liew D; Teo S; Davis SM; Yan B
Stroke; 2013 Aug; 44(8):2269-74. PubMed ID: 23780955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
